1. Impact of HAART and Metabolic Complications on Myocardial Infarction and Survival among HIV-infected Patients/ H. Crane

 

2. Assessing the Clinical Consequences of HIV Drug Resistance/ R Haubrich

 

3. Biological and behavioral correlates of ART adherence and depression across diverse patients in the CNICS cohorts./ S Saffren

 

4. The incidence and correlates of HIV superinfection before starting and after stopping antiretroviral therapy

 

5. Viral Variation and the Development of Neutralizing Antibodies

 

6. Predictors of Severe Liver Enzyme Elevation and Immunologic Response to Initial HAART in Patients with HIV and Hepatitis Co-Infection/ C Achenbach

 

7. Eligibility for Early Initiation of Highly Active Antiretroviral Therapy (HAART) to Decrease HIV Transmission/ J Dombrowski

 

8. Durability and Effectiveness of First-line ARV Regimens in treatment-naïve Patients Initiating Therapy in a Clinical Practice Setting/ M Mugavero

 

9. Association of cellular immune function and phenotype with severe liver enzyme elevation (LEE) after Highly Active Antiretroviral Therapy (HAART) among HIV and viral hepatitis co-infected patients/ C Achenbach

 

10. Long-term virologic outcomes of HIV-infected patients coinfected with hepatitis B on tenofovir-containing HAART/ N Kim

 

11. Prevalence and predictors of unprotected sex and substance use in the CNICS cohort./ M Mimiaga

 

12. Dynamic Assessment of Virologic Response and Mortality Among HIV-infected Patients Initiating Antiretroviral Therapy/ M Mugavero

 

13. An Analysis of Renal Function Before and After the Initiation of Highly Antiretroviral Therapy (HAART) to Examine Correlates of Renal Function Preservation and Decline/ R Kalayjian

 

14. HIV Pathogenesis and Immunity in Viremic Non-Progressors/ D Camerini

 

15. Predictors of HIV+ smokers and investigation of smoking recognition and intervention by providers in two HIV ambulatory clinics/ K Cropsey

 

16. Molecular Epidemiology of HIV Transmission and Transmitted Resistance in Women and Minorities in the CNICS Cohort. / J Aldous

 

17. HIV infection in sickle cell disease/ M Lederman

 

18. Comparison of plasma HIV RNA with CD4+ T cell count-based strategies for detection of first line treatment failure and initiation of regimen modification. / M Peterson

 

19. AIDS-defining and non-AIDS defining malignancies among the CFAR Network of Integrated Clinical Systems (CNICS)/ M Saag

 

20. Effects of Hepatitis B co-infection on HIV Antiretroviral Therapy Response and Long-term Outcomes/ S. Radke

 

21. Methods to migrate from the 9-item Patient Health Questionnaire (PHQ-9) to computerized adaptive administration of the Patient Reported Outcomes Measurement Information System (PROMIS) depression measure./ H. Crane

 

22. HIV Infection and Response to Initial Therapy for Type 2 Diabetes / J. Han

 

23. Contribution of enzyme (protease) and substrate (gag) mutations to protease inhibitor resistance / D. Looney

 

24. Epidemiology & Outcomes of HIV-2 in the United States/ G. Gottlieb

 

25. Adherence to Clinical Care and Survival among HIV-infected Patients Initiating Antiretroviral Therapy/ M Mugavero